Related references
Note: Only part of the references are listed.CAR T cells in solid tumors: challenges and opportunities
Faroogh Marofi et al.
STEM CELL RESEARCH & THERAPY (2021)
The emerging role of off-the-shelf engineered natural killer cells in targeted cancer immunotherapy
Kellsye P. Fabian et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
Recruitment, Infiltration, and Cytotoxicity of HLA-Independent Killer Lymphocytes in Three-Dimensional Melanoma Models
Ilenia Iaia et al.
CANCERS (2021)
3D Cancer Models: Depicting Cellular Crosstalk within the Tumour Microenvironment
Teresa Franchi-Mendes et al.
CANCERS (2021)
Three-Dimensional Culture Models to Study Innate Anti-Tumor Immune Response: Advantages and Disadvantages
Alessandro Poggi et al.
CANCERS (2021)
Tumor-on-a-chip: from bioinspired design to biomedical application
Xingxing Liu et al.
MICROSYSTEMS & NANOENGINEERING (2021)
CAR T-Cell Therapy in Hematologic Malignancies: A Voyage in Progress
Sarah A. Holstein et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Crosstalk between cancer-associated fibroblasts and immune cells in cancer
Yuanyuan An et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Could 3D models of cancer enhance drug screening?
Virginia Brancato et al.
BIOMATERIALS (2020)
3D models in the new era of immune oncology: focus on T cells, CAF and ECM
Francesca Di Modugno et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
The Emerging World of TCR-T Cell Trials Against Cancer: A Systematic Review
Jianxiang Zhang et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2019)
Evaluating CAR-T Cell Therapy in a Hypoxic 3D Tumor Model
Yuta Ando et al.
ADVANCED HEALTHCARE MATERIALS (2019)
Cancer-associated fibroblasts-heroes or villains?
Krystyna A. Gieniec et al.
BRITISH JOURNAL OF CANCER (2019)
Adoptive cellular therapies: the current landscape
Maartje W. Rohaan et al.
VIRCHOWS ARCHIV (2019)
CAR T-cell Therapy: A New Era in Cancer Immunotherapy
Miliotou N. Androulla et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2018)
Alteration of the Antitumor immune Response by Cancer-Associated Fibroblasts
Linda Ziani et al.
FRONTIERS IN IMMUNOLOGY (2018)
Optimized design and fabrication of a microfluidic platform to study single cells and multicellular aggregates in 3D
S. L. Marasso et al.
MICROFLUIDICS AND NANOFLUIDICS (2017)
Trial Watch: Adoptively transferred cells for anticancer immunotherapy
Carole Fournier et al.
ONCOIMMUNOLOGY (2017)
3D Microfluidic model for evaluating immunotherapy efficacy by tracking dendritic cell behaviour toward tumor cells
Stefania Parlato et al.
SCIENTIFIC REPORTS (2017)
Adoptive Cell Therapy for Metastatic Melanoma
Efrat Merhavi-Shoham et al.
CANCER JOURNAL (2017)
Natural Killer Cells for immunotherapy-Advantages of the NK-92 Cell Line over Blood NK Cells
Hans Klingemann et al.
FRONTIERS IN IMMUNOLOGY (2016)
Trial Watch: Adoptive cell transfer for oncological indications
Fernando Aranda et al.
ONCOIMMUNOLOGY (2015)
Immune-suppressive properties of the tumor microenvironment
Juergen C. Becker et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Effective Activity of Cytokine-Induced Killer Cells against Autologous Metastatic Melanoma Including Cells with Stemness Features
Loretta Gammaitoni et al.
CLINICAL CANCER RESEARCH (2013)
Hallmarks of cancer: Interactions with the tumor stroma
Kristian Pietras et al.
EXPERIMENTAL CELL RESEARCH (2010)
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
Steven A. Rosenberg et al.
NATURE REVIEWS CANCER (2008)
Cutting edge: Down-regulation of MICA on human tumors by proteolytic shedding
HR Salih et al.
JOURNAL OF IMMUNOLOGY (2002)